Clinical analysis of 42 primary hyperthyroidism patients complicated with thyroid microcarcinoma

Yan Cheng, Lingcheng Wang, Yaqiong Li, D. Cheng
{"title":"Clinical analysis of 42 primary hyperthyroidism patients complicated with thyroid microcarcinoma","authors":"Yan Cheng, Lingcheng Wang, Yaqiong Li, D. Cheng","doi":"10.3760/CMA.J.ISSN.1008-6706.2020.07.016","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the clinical data of primary hyperthyroidism patients complicated with thyroid microcarcinoma, and to guide clinical diagnosis and treatment. \n \n \nMethods \nFrom January 2013 to March 2019, the clinical data of 42 cases of hyperthyroidism with thyroid microcarcinoma(study group) and 410 cases of thyroid microcarcinoma without hyperthyroidism(control group) who underwent surgical treatment in the People's Hospital Affiliated to Hubei University of Medicine were retrospectively analyzed.The epidemiological characteristics, clinical diagnosis and treatment, clinical stage, B-ultrasound characteristics, thyroid function and antibody, pathological data and prognosis of the two groups were compared. \n \n \nResults \nIn study group and control group, the proportion of microcalcification detected by B-ultrasonography was 61.9%(26/42) and 33.4%(137/410), respectively, the difference was statistically significant between the two groups(χ2=13.411, P<0.05). In study group and control group, 47.62%(20/42) and 69.02%(283/410) of multifocal nodules were detected by B-ultrasound, the difference was statistically significant between the two groups(χ2=7.899, P<0.05). The diagnostic rates of intraoperative frozen-section examination of the study group and the control group were 61.9%(26/42) and 66.1%(271/410), respectively, the difference was statistically significant between the two groups(χ2=4.460, P<0.05). The lymph node metastasis rates of the study group and the control group were 9.5%(4/42) and 26.8%(110/410), respectively, the difference was statistically significant between the two groups(χ2=6.049, P<0.05). The middle follow-up period was 37 months(1 month to 74 months). There was no recurrence of thyroid cancer in the study group, 2 cases with recurrence of hyperthyroidism after operation, and 3 cases with recurrence in the control group, with secondary surgical resection.There were no deaths in the two groups during follow-up. \n \n \nConclusion \nThyroid cancer should be paid attention to when hyperthyroidism combined with nodules, but the prognosis of hyperthyroidism with microcarcinoma is better.The operation method tends to be bilateral lobectomy, which can prevent the recurrence of hyperthyroidism.In order to reduce the chance of parathyroid gland and recurrent laryngeal nerve injury, there may be no need of preventive lymph node dissection in area VI. \n \n \nKey words: \nHyperthyroidism; Thyroid neoplasms; Epidemiology; Ultrasonography; Pathology, clinical; Calcium compounds; Neoplasm staging; Lymphatic metastasis; Prognosis","PeriodicalId":10226,"journal":{"name":"中国基层医药","volume":"27 1","pages":"836-840"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国基层医药","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1008-6706.2020.07.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To analyze the clinical data of primary hyperthyroidism patients complicated with thyroid microcarcinoma, and to guide clinical diagnosis and treatment. Methods From January 2013 to March 2019, the clinical data of 42 cases of hyperthyroidism with thyroid microcarcinoma(study group) and 410 cases of thyroid microcarcinoma without hyperthyroidism(control group) who underwent surgical treatment in the People's Hospital Affiliated to Hubei University of Medicine were retrospectively analyzed.The epidemiological characteristics, clinical diagnosis and treatment, clinical stage, B-ultrasound characteristics, thyroid function and antibody, pathological data and prognosis of the two groups were compared. Results In study group and control group, the proportion of microcalcification detected by B-ultrasonography was 61.9%(26/42) and 33.4%(137/410), respectively, the difference was statistically significant between the two groups(χ2=13.411, P<0.05). In study group and control group, 47.62%(20/42) and 69.02%(283/410) of multifocal nodules were detected by B-ultrasound, the difference was statistically significant between the two groups(χ2=7.899, P<0.05). The diagnostic rates of intraoperative frozen-section examination of the study group and the control group were 61.9%(26/42) and 66.1%(271/410), respectively, the difference was statistically significant between the two groups(χ2=4.460, P<0.05). The lymph node metastasis rates of the study group and the control group were 9.5%(4/42) and 26.8%(110/410), respectively, the difference was statistically significant between the two groups(χ2=6.049, P<0.05). The middle follow-up period was 37 months(1 month to 74 months). There was no recurrence of thyroid cancer in the study group, 2 cases with recurrence of hyperthyroidism after operation, and 3 cases with recurrence in the control group, with secondary surgical resection.There were no deaths in the two groups during follow-up. Conclusion Thyroid cancer should be paid attention to when hyperthyroidism combined with nodules, but the prognosis of hyperthyroidism with microcarcinoma is better.The operation method tends to be bilateral lobectomy, which can prevent the recurrence of hyperthyroidism.In order to reduce the chance of parathyroid gland and recurrent laryngeal nerve injury, there may be no need of preventive lymph node dissection in area VI. Key words: Hyperthyroidism; Thyroid neoplasms; Epidemiology; Ultrasonography; Pathology, clinical; Calcium compounds; Neoplasm staging; Lymphatic metastasis; Prognosis
原发性甲状腺机能亢进合并甲状腺微癌42例临床分析
目的分析原发性甲状腺功能亢进症合并甲状腺微小癌的临床资料,指导临床诊治。方法回顾性分析2013年1月至2019年3月在湖北医科大学附属人民医院接受手术治疗的42例甲状腺功能亢进伴甲状腺微小癌(研究组)和410例无甲状腺功能亢进的甲状腺微小癌的临床资料。比较两组患者的流行病学特点、临床诊治、临床分期、B超特点、甲状腺功能及抗体、病理资料及预后。结果研究组和对照组B超检出微钙化的比例分别为61.9%(26/42)和33.4%(137/410),两组差异有统计学意义(χ2=13.411,P<0.05),两组比较差异有统计学意义(χ2=7.899,P<0.05)。研究组和对照组术中冰冻切片检查的诊断率分别为61.9%(26/42)和66.1%(271/410),研究组和对照组的淋巴结转移率分别为9.5%(4/42)和26.8%(110/410),两组间差异有统计学意义(χ2=6.049,P<0.05),中期随访37个月(1个月~74个月)。研究组甲状腺癌症无复发,术后甲状腺功能亢进复发2例,对照组复发3例,均行二次手术切除。随访期间,两组患者均未死亡。结论甲状腺功能亢进合并结节应引起癌症的重视,但甲状腺功能亢进伴微小癌预后较好。手术方法倾向于双侧肺叶切除术,可以防止甲状腺功能亢进症的复发。为了减少甲状旁腺和喉返神经损伤的机会,可能不需要在六区进行预防性淋巴结清扫。关键词:甲状腺功能亢进;甲状腺肿瘤;流行病学;超声检查;病理学,临床;钙化合物;肿瘤分期;淋巴结转移;预后
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
32251
期刊介绍: Since its inception, the journal "Chinese Primary Medicine" has adhered to the development strategy of "based in China, serving the grassroots, and facing the world" as its publishing concept, reporting a large amount of the latest medical information at home and abroad, prospering the academic field of primary medicine, and is praised by readers as a medical encyclopedia that updates knowledge. It is a core journal in China's medical and health field, and its influence index (CI) ranks Q2 in China's academic journals in 2022. It was included in the American Chemical Abstracts in 2008, the World Health Organization Western Pacific Regional Medical Index (WPRIM) in 2009, and the Japan Science and Technology Agency Database (JST) and Scopus Database in 2018, and was included in the Wanfang Data-China Digital Journal Group and the China Academic Journal Comprehensive Evaluation Database.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信